Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 1 | 2004 | 17 | 0.230 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2004 | 35 | 0.220 |
Why?
|
| Intestine, Small | 1 | 2004 | 75 | 0.220 |
Why?
|
| Stomach Diseases | 1 | 2022 | 10 | 0.200 |
Why?
|
| Stomach Neoplasms | 1 | 2003 | 74 | 0.200 |
Why?
|
| Choristoma | 1 | 2022 | 24 | 0.200 |
Why?
|
| Rectal Diseases | 1 | 2022 | 27 | 0.200 |
Why?
|
| Pancreatic Fistula | 1 | 2021 | 18 | 0.190 |
Why?
|
| Diaphragm | 1 | 2021 | 23 | 0.190 |
Why?
|
| Immunoconjugates | 1 | 2021 | 84 | 0.180 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 65 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 329 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 621 | 0.170 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 50 | 0.140 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2016 | 7 | 0.130 |
Why?
|
| Pancreas, Exocrine | 1 | 2016 | 12 | 0.130 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2016 | 62 | 0.130 |
Why?
|
| Pancreatectomy | 1 | 2016 | 96 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2016 | 271 | 0.110 |
Why?
|
| Laparoscopy | 1 | 2017 | 401 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 328 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2011 | 3 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 13 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 138 | 0.090 |
Why?
|
| Middle Aged | 7 | 2022 | 16552 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 466 | 0.070 |
Why?
|
| Leiomyomatosis | 1 | 2006 | 3 | 0.070 |
Why?
|
| Hormone Antagonists | 1 | 2006 | 12 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2006 | 31 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 87 | 0.070 |
Why?
|
| Humans | 10 | 2022 | 60164 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1066 | 0.060 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 129 | 0.050 |
Why?
|
| Zona Pellucida | 1 | 2003 | 13 | 0.050 |
Why?
|
| Gastritis, Atrophic | 1 | 2003 | 3 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2004 | 156 | 0.050 |
Why?
|
| Metaplasia | 1 | 2003 | 18 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2003 | 23 | 0.050 |
Why?
|
| Male | 5 | 2022 | 27987 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2004 | 117 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2003 | 56 | 0.050 |
Why?
|
| Helicobacter pylori | 1 | 2003 | 59 | 0.050 |
Why?
|
| Gastric Mucosa | 1 | 2022 | 49 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 151 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2004 | 224 | 0.050 |
Why?
|
| Female | 7 | 2022 | 31257 | 0.050 |
Why?
|
| Adult | 5 | 2022 | 15989 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 855 | 0.050 |
Why?
|
| Rectum | 1 | 2022 | 85 | 0.050 |
Why?
|
| Tobacco Use | 1 | 2021 | 37 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 910 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2021 | 74 | 0.040 |
Why?
|
| Risk Factors | 2 | 2016 | 5091 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1471 | 0.040 |
Why?
|
| Disease Progression | 1 | 2003 | 1054 | 0.040 |
Why?
|
| Alcoholism | 1 | 2021 | 308 | 0.040 |
Why?
|
| Operative Time | 1 | 2017 | 68 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 406 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2017 | 74 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 1481 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 854 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 61 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 77 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2017 | 6147 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 211 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 782 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 850 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 39 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 5267 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 288 | 0.020 |
Why?
|
| Proteomics | 1 | 2011 | 264 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 3623 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 71 | 0.020 |
Why?
|
| Uterus | 1 | 2006 | 41 | 0.020 |
Why?
|
| Organ Size | 1 | 2006 | 165 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2006 | 71 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 5202 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 4401 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2006 | 177 | 0.020 |
Why?
|
| Animals | 1 | 2003 | 19775 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2006 | 684 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 806 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 2003 | 15 | 0.010 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2003 | 32 | 0.010 |
Why?
|
| Blastocyst | 1 | 2003 | 76 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 13599 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2003 | 3132 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 2367 | 0.010 |
Why?
|